BPP 9a is a proline-rich sequence with characteristic structural rigidity enabling stable conformational states. The motif supports receptor-interface modeling and surface-binding analysis. Its physicochemical properties lend themselves to biophysical characterization. Applications include inhibitory motif studies, peptide folding evaluation, and ligand-target exploration.
CAT No: B08011
CAS No:35115-60-7
Synonyms/Alias:TEPROTIDE;35115-60-7;Angiotensin Converting Enzyme Inhibitor;Tepromide;Teprotido;Teprotidum;teprotida;angiotensin-converting enzyme inhibitor;Teprotidum [INN-Latin];SQ 20881;SQ-20881;Teprotido [INN-Spanish];C3E5QBF1R6;Teprotide [USAN:INN:BAN];CCRIS 9333;TEPROTIDE [INN];Teprotide (USAN/INN);TEPROTIDE [USAN];TEPROTIDE [MART.];SO-20881;5-Oxo-L-prolyl-L-tryptophyl-L-prolyl-L-arginyl-L-prolyl-L-glutaminyl-L-isoleucyl-L-prolyl-L-proline;CHEBI:9444;CHEMBL408983;(2S)-1-[(2S)-1-[(2S,3S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S)-3-(1H-indol-3-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid;DTXSID301029698;SO 20881;Teprotidum (INN-Latin);Teprotido (INN-Spanish);TEPROTIDE (MART.);Bradykinin potentiator B, 2-L-tryptophan-3-de-L-leucine-4-de-L-proline-8-L-glutamine-;Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro;(2S)-1-[(2S)-1-[(2S,3S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-5-guanidino-2-[[(2S)-1-[(2S)-3-(1H-indol-3-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxo-pentanoyl]amino]-3-methyl-pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid;BPP-9a;AC1L9EJT;UNII-C3E5QBF1R6;Bradykinin Potentiating Peptide 9a;Bradykinin-Potentiating Peptide 9a;(2S)-1-((2S)-1-((2S,3S)-2-(((2S)-5-amino-2-(((2S)-1-((2S)-5-guanidino-2-(((2S)-1-((2S)-3-(1H-indol-3-yl)-2-(((2S)-5-oxopyrrolidine-2-carbonyl)amino)propanoyl)pyrrolidine-2-carbonyl)amino)pentanoyl)pyrrolidine-2-carbonyl)amino)-5-oxo-pentanoyl)amino)-3-methyl-pentanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxylic acid;Peptide 9a, Bradykinin-Potentiating;Nonapeptide Converting Enzyme Inhibitor;Nonapeptide-Converting Enzyme Inhibitor;Enzyme Inhibitor, Nonapeptide-Converting;SCHEMBL613757;SCHEMBL11855843;DTXCID601514903;HY-P2366;MFCD00076208;FB108627;CS-0133127;NS00125817;D06076;G77853;BPP 9a Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH;Q7701390;Angiotensin Converting Enzyme Inhibitor, >=95% (TLC);Pyroglutamyl-tryptophyl-prolyl-arginyl-prolyl-glutaminyl-isoleucyl-prolyl-proline;L-Pyroglutamyl-L-tryptophyl-L-prolyl-L-arginyl-L-prolyl-L-glutaminyl-L-isoleucyl-L-prolyl-L-proline;
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
2. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More